Lesseur, CorinaDiergaarde, BrendaOlshan, Andrew FWünsch-Filho, VictorNess, Andrew RLiu, GeoffreyLacko, MartinEluf-Neto, JoséFranceschi, SilviaLagiou, PagonaMacfarlane, Gary JRichiardi, LorenzoBoccia, StefaniaPolesel, JerryKjaerheim, KristinaZaridze, DavidJohansson, MattiasMenezes, Ana MCurado, Maria PaulaRobinson, MaxAhrens, WolfgangCanova, CristinaZnaor, ArianaCastellsagué, XavierConway, David IHolcátová, IvanaMates, DanaVilensky, MartaHealy, Claire MSzeszenia-Dąbrowska, NeonilaFabiánová, EleonóraLissowska, JolantaGrandis, Jennifer RWeissler, Mark CTajara, Eloiza HNunes, Fabio Dde Carvalho, Marcos BThomas, SteveHung, Rayjean JPeters, Wilbert H MHerrero, RolandoCadoni, GabriellaBueno-de-Mesquita, H BasSteffen, AnnikaAgudo, AntonioShangina, OxanaXiao, XiangjunGaborieau, ValérieChabrier, AmélieAnantharaman, DevasenaBoffetta, PaoloAmos, Christopher IMcKay, James DBrennan, Paul2017-04-172017-04-172016-12Lesseur, C, Diergaarde, B, Olshan, A F, Wünsch-Filho, V, Ness, A R, Liu, G, Lacko, M, Eluf-Neto, J, Franceschi, S, Lagiou, P, Macfarlane, G J, Richiardi, L, Boccia, S, Polesel, J, Kjaerheim, K, Zaridze, D, Johansson, M, Menezes, A M, Curado, M P, Robinson, M, Ahrens, W, Canova, C, Znaor, A, Castellsagué, X, Conway, D I, Holcátová, I, Mates, D, Vilensky, M, Healy, C M, Szeszenia-Dąbrowska, N, Fabiánová, E, Lissowska, J, Grandis, J R, Weissler, M C, Tajara, E H, Nunes, F D, de Carvalho, M B, Thomas, S, Hung, R J, Peters, W H M, Herrero, R, Cadoni, G, Bueno-de-Mesquita, H B, Steffen, A, Agudo, A, Shangina, O, Xiao, X, Gaborieau, V, Chabrier, A, Anantharaman, D, Boffetta, P, Amos, C I, McKay, J D & Brennan, P 2016, 'Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer', Nature Genetics, vol. 48, no. 12, pp. 1544-1550. https://doi.org/10.1038/ng.36851061-4036PubMedCentral: PMC5131845ORCID: /0000-0003-2322-3314/work/31890014http://hdl.handle.net/2164/8502Genotyping performed at the Center for Inherited Disease Research (CIDR) was funded through US National Institute of Dental and Craniofacial Research (NIDCR) grant 1X01HG007780-0. Genotyping for shared controls with the Lung OncoArray initiative was funded through grant X01HG007492-0. C.L. undertook this work during the tenure of a postdoctoral fellowship awarded by the International Agency for Research on Cancer. The funders did not participate in study design, data collection and analysis, decision to publish or preparation of the manuscript. We acknowledge all of the participants involved in this research and the funders and support. We thank L. Fernandez for her contribution to the IARC ORC multicenter study. We are also grateful to S. Koifman for his contribution to the IARC Latin America multicenter study (S. Koifman passed away in May 2014) and to X. Castellsagué who recently passed away (June 2016). The University of Pittsburgh head and neck cancer case–control study is supported by US National Institutes of Health grants P50CA097190 and P30CA047904. The Carolina Head and Neck Cancer Study (CHANCE) was supported by the National Cancer Institute (R01CA90731). The Head and Neck Genome Project (GENCAPO) was supported by the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP; grants 04/12054-9 and 10/51168-0). The authors thank all the members of the GENCAPO team. The HN5000 study was funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research scheme (RP-PG-0707-10034); the views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the UK Department of Health. The Toronto study was funded by the Canadian Cancer Society Research Institute (020214) and the National Cancer Institute (U19CA148127) and by the Cancer Care Ontario Research Chair. The Alcohol-Related Cancers and Genetic Susceptibility Study in Europe (ARCAGE) was funded by the European Commission's fifth framework programme (QLK1-2001-00182), the Italian Association for Cancer Research, Compagnia di San Paolo/FIRMS, Region Piemonte and Padova University (CPDA057222). The Rome Study was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC) awards IG 2011 10491 and IG 2013 14220 to S.B. and by Fondazione Veronesi to S.B. The IARC Latin American study was funded by the European Commission INCO-DC programme (IC18-CT97-0222), with additional funding from Fondo para la Investigación Científica y Tecnológica (Argentina) and the Fundação de Amparo à Pesquisa do Estado de São Paulo (01/01768-2). The IARC Central Europe study was supported by the European Commission's INCO-COPERNICUS Program (IC15-CT98-0332), US NIH/National Cancer Institute grant CA92039 and World Cancer Research Foundation grant WCRF 99A28.The IARC Oral Cancer Multicenter study was funded by grant S06 96 202489 05F02 from Europe against Cancer; grants FIS 97/0024, FIS 97/0662 and BAE 01/5013 from Fondo de Investigaciones Sanitarias, Spain; the UICC Yamagiwa-Yoshida Memorial International Cancer Study; the National Cancer Institute of Canada; Associazione Italiana per la Ricerca sul Cancro; and the Pan-American Health Organization. Coordination of the EPIC study is financially supported by the European Commission (DG SANCO) and the International Agency for Research on Cancer.716981842058114engSDG 3 - Good Health and Well-beingepidemiologygenetics researchgenome-wide association studiesoral cancerR MedicineRJournal item10.1038/ng.36854812